{3 minutes to read} In a new case, Eli Lilly & Co. v. Teva Parenteral Medicines, Inc., the Federal Circuit affirmed the lower court’s decision finding of patent infringement under Akamai. The appeal arose from an Abbreviated New Drug Application (ANDA) litigation describing to take ALIMTA® [pemetrexed sodium] with folic acid and vitamin B12 to […]
